All Stories

  1. Cutaneous delivery and biodistribution of a lipophilic natural product – bakuchiol: Comparing nanocarrier performance
  2. Trends and Commonalities of Approved and Late Clinical-Phase RNA Therapeutics
  3. Development of an ex vivo human skin model and evaluation of biological responses to subcutaneously injected hyaluronic acid formulations
  4. Non-Invasive Delivery of Negatively Charged Nanobodies by Anodal Iontophoresis: When Electroosmosis Dominates Electromigration
  5. Cutaneous Delivery and Biodistribution of Cannabidiol in Human Skin after Topical Application of Colloidal Formulations
  6. Clinical Perspectives on the Injectability of Cross-Linked Hyaluronic Acid Dermal Fillers: A Standardized Methodology for Commercial Product Benchmarking with Inter-Injector Assessments
  7. Enhancing Oral Delivery of Biologics: A Non-Competitive and Cross-Reactive Anti-Leptin Receptor Nanofitin Demonstrates a Gut-Crossing Capacity in an Ex Vivo Porcine Intestinal Model
  8. Development of an ex vivo porcine skin model for the preclinical evaluation of subcutaneously injected biomacromolecules
  9. Enhanced topical paromomycin delivery for cutaneous leishmaniasis treatment: Passive and iontophoretic approaches
  10. Polymeric micelles for cutaneous delivery of the hedgehog pathway inhibitor TAK-441: Formulation development and cutaneous biodistribution in porcine and human skin
  11. Injectable Hyaluronan-Based Thermoresponsive Hydrogels for Dermatological Applications
  12. Influence of Molecular Structure and Physicochemical Properties of Immunosuppressive Drugs on Micelle Formulation Characteristics and Cutaneous Delivery
  13. Non-Invasive Iontophoretic Delivery of Cytochrome c to the Posterior Segment and Determination of Its Ocular Biodistribution
  14. Simultaneous Delivery of Econazole, Terbinafine and Amorolfine with Improved Cutaneous Bioavailability: A Novel Micelle-Based Antifungal “Tri-Therapy”
  15. Effect of mRNA Delivery Modality and Formulation on Cutaneous mRNA Distribution and Downstream eGFP Expression
  16. Controlled simultaneous iontophoresis of buflomedil hydrochloride and dexamethasone sodium phosphate to the mucosa for oral submucous fibrosis
  17. DESI-MS imaging to visualize spatial distribution of xenobiotics and endogenous lipids in the skin
  18. Current profile controlled transdermal delivery of pramipexole from an iontophoretic patch system in vitro and in vivo
  19. Using Porcine Jejunum Ex Vivo to Study Absorption and Biotransformation of Natural Products in Plant Extracts: Pueraria lobata as a Case Study
  20. Microemulsion-based gel for the transdermal delivery of rasagiline mesylate: In vitro and in vivo assessment for Parkinson’s therapy
  21. Polymeric micelle mediated follicular delivery of spironolactone: Targeting the mineralocorticoid receptor to prevent glucocorticoid-induced activation and delayed cutaneous wound healing
  22. Polymeric micelle formulations for the cutaneous delivery of sirolimus: A new approach for the treatment of facial angiofibromas in tuberous sclerosis complex
  23. The influence of skin barrier impairment on the iontophoretic transport of low and high molecular weight permeants
  24. Effect of continuous and multi-phasic current profiles on the iontophoretic transport of pramipexole, rasagiline and huperzine A: Depicting temporal variation and biodistribution in the skin
  25. Co-administration of zinc phthalocyanine and quercetin via hybrid nanoparticles for augmented photodynamic therapy
  26. Iontosomes: Electroresponsive Liposomes for Topical Iontophoretic Delivery of Chemotherapeutics to the Buccal Mucosa
  27. Using protease inhibitors to improve protein stability in the presence of skin: A case study on the stability of insulin like growth factor 1
  28. Withdrawal notice to ‘WITHDRAWN: Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1B and a poly-ARG interferon beta-1B analogue’ [International Journal of Pharmaceutics 589 (2020) 119913]
  29. Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1b and a poly-Arg interferon beta-1b analogue
  30. Using Ex Vivo Porcine Jejunum to Identify Membrane Transporter Substrates: A Screening Tool for Early—Stage Drug Development
  31. Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1B and a poly-ARG interferon beta-1B analogue
  32. Tissue Levels of Flurbiprofen in the Rat Plantar Heel after Short-Duration Topical Iontophoresis are Sufficient to Induce Pharmacodynamic Responses to Local Pain Stimuli
  33. Targeted cutaneous delivery of etanercept using Er:YAG fractional laser ablation
  34. Non-invasive targeted iontophoretic delivery of cetuximab to skin
  35. Ocular Biodistribution of Spironolactone after a Single Intravitreal Injection of a Biodegradable Sustained-Release Polymer in Rats
  36. Cutaneous Biodistribution: A High-Resolution Methodology to Assess Bioequivalence in Topical Skin Delivery
  37. Topical iontophoresis of buflomedil hydrochloride increases drug bioavailability in the mucosa: A targeted approach to treat oral submucous fibrosis
  38. Using ordered mesoporous silica sba-15 to limit cutaneous penetration and transdermal permeation of organic uv filters
  39. Controlled Iontophoretic Delivery in Vitro and in Vivo of ARN14140—A Multitarget Compound for Alzheimer’s Disease
  40. Er:YAG fractional laser ablation for cutaneous co-delivery of pentoxifylline and d-α-tocopherol succinate: A new approach for topical treatment of radiation-induced skin fibrosis
  41. Delivering vismodegib directly to the skin
  42. Drug Transport across Porcine Intestine Using an Ussing Chamber System: Regional Differences and the Effect of P-Glycoprotein and CYP3A4 Activity on Drug Absorption
  43. Fractional laser ablation for the targeted cutaneous delivery of an anti-CD29 monoclonal antibody – OS2966
  44. Self-assembled mPEG-hexPLA polymeric nanocarriers for the targeted cutaneous delivery of imiquimod
  45. Strategies for modifying drug residence time and ocular bioavailability to decrease treatment frequency for back of the eye diseases
  46. Investigation of Different Iontophoretic Currents Profiles for Short-Term Applications in Cosmetics
  47. Controlled non-invasive iontophoretic delivery of triamcinolone acetonide amino acid ester prodrugs into the posterior segment of the eye
  48. Hyaluronic Acid After Subcutaneous Injection—An Objective Assessment
  49. Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo : Transdermal polypharmacy to treat Parkinson’s disease
  50. Hydrogels in three-dimensional dendritic cell (MUTZ-3) culture as a scaffold to mimic human immuno competent subcutaneous tissue
  51. Needle-free cutaneous delivery of living human cells by Er:YAG fractional laser ablation
  52. Development and validation of a fast and sensitive UHPLC-ESI-MS method for the simultaneous quantification of spironolactone and its metabolites in ocular tissues.
  53. Topical Administration of Spironolactone-Loaded Nanomicelles Prevents Glucocorticoid-Induced Delayed Corneal Wound Healing in Rabbits
  54. Selective delivery of adapalene to the human hair follicle under finite dose conditions using polymeric micelle nanocarriers
  55. Short-duration ocular iontophoresis of ionizable aciclovir prodrugs: A new approach to treat herpes simplex infections in the anterior and posterior segments of the eye
  56. Targeted intracorneal delivery—Biodistribution of triamcinolone acetonide following topical iontophoresis of cationic amino acid ester prodrugs
  57. Formulation challenges for 21st century topical and transdermal delivery systems
  58. Cutaneous iontophoresis of μ-conotoxin CnIIIC—A potent NaV1.4 antagonist with analgesic, anaesthetic and myorelaxant properties
  59. Transdermal therapeutic systems for memantine delivery. Comparison of passive and iontophoretic transport
  60. Basic principles and current status of transcorneal and transscleral iontophoresis
  61. Improved topical delivery of tacrolimus: A novel composite hydrogel formulation for the treatment of psoriasis
  62. Erratum to “Topical iontophoretic delivery of ionizable, biolabile aciclovir prodrugs: A rational approach to improve cutaneous bioavailability” [Eur. J. Pharm. Biopharm. 99 (2016) 103–113]
  63. Topical delivery of diclofenac into and across equine skin from a novel liquid diclofenac epolamine formulation
  64. Controlled transdermal iontophoresis for poly-pharmacotherapy: Simultaneous delivery of granisetron, metoclopramide and dexamethasone sodium phosphate in vitro and in vivo
  65. A UHPLC-UV Method to Quantify Skin Deposition and Transdermal Permeation of Tizanidine Hydrochloride
  66. Cutaneous biodistribution of ionizable, biolabile aciclovir prodrugs after short duration topical iontophoresis: Targeted intraepidermal drug delivery
  67. Fractional Laser Ablation for the Cutaneous Delivery of Triamcinolone Acetonide from Cryomilled Polymeric Microparticles: Creating Intraepidermal Drug Depots
  68. Topical iontophoretic delivery of ionizable, biolabile aciclovir prodrugs: A rational approach to improve cutaneous bioavailability
  69. Polymeric Micelles in Dermal and Transdermal Delivery
  70. Synthesis of 3-azabicyclo[3.2.2]nonanes and their antiprotozoal activities
  71. Transdermal patches: history, development and pharmacology
  72. Self-assembled polymeric nanocarriers for the targeted delivery of retinoic acid to the hair follicle
  73. Targeted cutaneous delivery of ciclosporin A using micellar nanocarriers and the possible role of inter-cluster regions as molecular transport pathways
  74. Colloidal Soft Nanocarrier for Transdermal Delivery of Dopamine Agonist: Ex Vivo and In Vivo Evaluation
  75. Polymeric Micelle Nanocarriers for the Cutaneous Delivery of Tacrolimus: A Targeted Approach for the Treatment of Psoriasis
  76. Controlled iontophoretic delivery of pramipexole: Electrotransport kinetics in vitro and in vivo
  77. Understanding the poor iontophoretic transport of lysozyme across the skin: When high charge and high electrophoretic mobility are not enough
  78. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: Demonstrating local enhanced topical drug delivery to muscle
  79. Targeted local simultaneous iontophoresis of chemotherapeutics for topical therapy of head and neck cancers
  80. Next generation intra- and transdermal therapeutic systems: Using non- and minimally-invasive technologies to increase drug delivery into and across the skin
  81. Controlled Iontophoretic Transport of Huperzine A across Skinin Vitroandin Vivo: Effect of Delivery Conditions and Comparison of Pharmacokinetic Models
  82. Controlled intra- and transdermal protein delivery using a minimally invasive Erbium:YAG fractional laser ablation technology
  83. Microstructured bicontinuous phase formulations: their characterization and application in dermal and transdermal drug delivery
  84. Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A
  85. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier
  86. Turning Theory into Practice: The Development of Modern Transdermal Drug Delivery Systems and Future Trends
  87. Comparison of the cutaneous iontophoretic delivery of rasagiline and selegiline across porcine and human skin in vitro
  88. Transcutaneous vaccination via laser microporation
  89. The Pharmaceutical Biochemistry Group: Where Pharmaceutical Chemistry Meets Biology and Drug Delivery
  90. Cutaneous iontophoretic delivery of CGP69669A, a sialyl Lewisx mimetic, in vitro
  91. Clinical Applications of Transdermal Iontophoresis
  92. Erbium:YAG fractional laser ablation for the percutaneous delivery of intact functional therapeutic antibodies
  93. Development and validation of a HPAE-PAD method for the quantification of CGP69669A, a sialyl Lewisx mimetic, in skin permeation studies
  94. Noninvasive Transdermal Iontophoretic Delivery of Biologically Active Human Basic Fibroblast Growth Factor
  95. Using laser microporation to improve transdermal delivery of diclofenac: Increasing bioavailability and the range of therapeutic applications
  96. Novel micelle formulations to increase cutaneous bioavailability of azole antifungals
  97. Electrically-assisted delivery of an anionic protein across intact skin: Cathodal iontophoresis of biologically active ribonuclease T1
  98. Human growth hormone: New delivery systems, alternative routes of administration, and their pharmacological relevance
  99. Non-invasive iontophoretic delivery of peptides and proteins across the skin
  100. Comparing metoclopramide electrotransport kinetics in vitro and in vivo
  101. Development and validation of a rapid high-performance liquid chromatography method for the quantification of exenatide
  102. Effect of controlled laser microporation on drug transport kinetics into and across the skin
  103. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6kDa) across intact porcine and human skins
  104. Transdermal iontophoresis of dexamethasone sodium phosphate in vitro and in vivo: Effect of experimental parameters and skin type on drug stability and transport kinetics
  105. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: Effect of experimental conditions and a comparison with other enhancement strategies
  106. Development and validation of an analytical method for the quantification of cytochrome c in skin transport studies
  107. Stability of triptorelin in the presence of dermis and epidermis
  108. Controlled non-invasive transdermal iontophoretic delivery of zolmitriptan hydrochloride in vitro and in vivo
  109. In vitro evaluation of the effect of electrotreatment on skin permeability
  110. Effect of propylene glycol on ibuprofen absorption into human skin in vivo
  111. In Vivo Methods for the Assessment of Topical Drug Bioavailability
  112. In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate
  113. Transdermal Delivery of Cytochrome C—A 12.4 kDa Protein—Across Intact Skin by Constant–Current Iontophoresis
  114. Dermatopharmacokinetic Prediction of Topical Drug Bioavailability In Vivo
  115. Ibuprofen Transport into and through Skin from Topical Formulations: In Vitro–In Vivo Comparison
  116. Structure–permeation relationships for the non-invasive transdermal delivery of cationic peptides by iontophoresis
  117. Topical Iontophoresis of Valaciclovir Hydrochloride Improves Cutaneous Aciclovir Delivery
  118. Pig Ear Skin ex Vivo as a Model for in Vivo Dermatopharmacokinetic Studies in Man
  119. New Developments in Topical Antifungal Therapy
  120. Capillary zone electrophoresis for the estimation of transdermal iontophoretic mobility
  121. Effect of amino acid sequence on transdermal iontophoretic peptide delivery
  122. Contributions of electromigration and electroosmosis to peptide iontophoresis across intact and impaired skin
  123. Yannic B. Schuetz, Aarti Naik, Richard H. Guy, Evelyne Vuaridel, Yogeshvar N. Kalia. Transdermal Iontophoretic Delivery of Triptorelin In Vitro. 94:2175-2182, 2005
  124. Transdermal Iontophoretic Delivery of Triptorelin in Vitro
  125. Effect of Charge and Molecular Weight on Transdermal Peptide Delivery by Iontophoresis
  126. Transdermal Iontophoretic Delivery of Vapreotide Acetate AcrossPorcine Skin in Vitro
  127. Skin permeation enhancement by sucrose esters: A pH-dependent phenomenon
  128. Emerging strategies for the transdermal delivery of peptide and protein drugs
  129. Development of an in vitro model for premature neonatal skin: Biophysical characterization using transepidermal water loss
  130. Assessment of Topical Bioavailability in vivo: The Importance of Stratum corneum Thickness
  131. Iontophoretic Transport across the Skin
  132. Enhancement of Topical Delivery from Biodegradable Nanoparticles
  133. Skin penetration and distribution of polymeric nanoparticles
  134. Visualization of skin penetration using confocal laser scanning microscopy
  135. Porcine Ear Skin as a Model for the Assessment of Transdermal Drug Delivery to Premature Neonates
  136. Iontophoretic drug delivery
  137. Non-invasive assessment of the effect of formulation excipients on stratum corneum barrier function in vivo
  138. Ultrasound‐Enhanced Transdermal Transport
  139. Skin Permeability Enhancement by Low Frequency Sonophoresis: Lipid Extraction and Transport Pathways
  140. Frequency and thermal effects on the enhancement of transdermal transport by sonophoresis
  141. Biophysical Study of Porcine Ear Skin In Vitro and Its Comparison to Human Skin In Vivo
  142. Reverse iontophoretic monitoring in premature neonates: feasibility and potential
  143. In vivo assessment of skin electroporation using square wave pulses
  144. Post-iontophoresis recovery of human skin impedance in vivo
  145. Piroxicam delivery into human stratum corneum in vivo: iontophoresis versus passive diffusion
  146. Passive skin penetration enhancement and its quantification in vitro
  147. Stabilization of supersaturated solutions of a lipophilic drug for dermal delivery
  148. Modeling transdermal drug release
  149. Enhanced skin permeation of a lipophilic drug using supersaturated formulations
  150. Non-invasive assessment of the effects of iontophoresis on human skin in-vivo
  151. Effect of ethanol and isopropyl myristate on the availability of topical terbinafine in human stratum corneum, in vivo
  152. In vivo assessment of enhanced topical delivery of terbinafine to human stratum corneum
  153. Factors and strategies for improving buccal absorption of peptides
  154. Recovery of human skin impedance in vivo after lontophoresis: Effect of metal ions
  155. Transdermal drug delivery: overcoming the skin’s barrier function
  156. Iontophoresis: electrorepulsion and electroosmosis
  157. Ion mobility across human stratum corneum in vivo
  158. Development of Skin Barrier Function in Premature Infants
  159. TRANSDERMAL DRUG DELIVERY
  160. Mechanisms of oral permeation enhancement
  161. Transdermal therapy and diagnosis by iontophoresis
  162. Characterization of the permeability barrier of human skin in vivo
  163. Interaction between penetration enhancers and iontophoresis: effect on human skin impedance in vivo
  164. Transdermal delivery of peptides by iontophoresis
  165. Protein-protein recognition mediated by a mini-protein domain: Possible evolutionary significance
  166. Amperometric enzyme electrodes